Financials
Income statement
Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
---|---|---|---|---|
Total reported revenue | 4.0B | 3.3B | 3.2B | 6.7B |
Cost of revenue | 937M | 823M | 783M | 1.1B |
Gross profit | 3.0B | 2.5B | 2.4B | 5.7B |
Operating expense | ||||
Research & development | 716M | 704M | 725M | 671M |
Selling general and admin | 1.6B | 1.4B | 1.5B | 1.8B |
Other operating expenses | — | — | — | — |
Operating income | 597M | 284M | 85M | 3.1B |
Non operating interest income | ||||
Income | 34M | 42M | 59M | 34M |
Expense | 60M | 60M | 61M | 60M |
Other income expense | — | -53M | — | -12M |
Pretax income | 571M | 213M | -140M | 3.1B |
Tax provision | 100M | 16M | -120M | 683M |
Net income | 471M | 197M | -20M | 2.4B |
Basic EPS | 1.7 | 0.7 | -0.1 | 8.5 |
Diluted EPS | 1.7 | 0.7 | -0.1 | 8.4 |
Basic average shares | 280M | 280M | 280M | 280M |
Diluted average shares | 283M | 283M | 280M | 284M |
EBITDA | 835M | 525M | 129M | 3.3B |
Net income from continuing op. | 471M | 197M | -20M | 2.4B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |